Articles

The AVBCC Summit is a great opportunity to hear from different stakeholders and meet some very brilliant people, said Peter Tun, Manager, Magnolia Innovation. And, it offers the chance to focus on the changing oncology landscape.

Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says that few conferences have the breadth of thought leaders who are present at AVBCC with the opportunity to move cancer care forward.

"We have done a lot of good work--but we still have a lot of work to do," said Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health. He added, "we need to regain momentum" that was stalled during the pandemic.

Sharing Insights for mutual benefit is what Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says is a key factor in attending AVBCC Summit.

Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, wants to put the individual patient at the center of cancer care, and this requires stakeholders to focus on this goal together, he said.

Value-based pharmaceutical design, government plans for CMS, and discussion of incentivizing high-value, low-cost care, are a few of the things to prioritize for future meetings, said Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health.

Lelan Wilfong, MD, VP, Payer Relations & Value-Based Transformation, McKesson Specialty Health, says his colleagues should attend AVBCC because it is a great place to come together to facilitate the process of innovation.